ライフサイエンスコーパス: reduce the risk of

1 Managing the carbon debt with prescribed fire will help reduce the risk of additional mortality from wildfire, but at

2 , while precipitating the allergen at the injection site to reduce the risk of anaphylaxis.

3 ifies ten double-duty actions that have strong potential to reduce the risk of both undernutrition, obesity, and DR-NCDs.

4 d-pressure-lowering drugs, and aspirin has been proposed to reduce the risk of cardiovascular disease.

5 The importance of maintaining COC should be emphasized to reduce the risk of CVD among hypertension patients.

6 enables detection of lung cancer at an early stage and can reduce the risk of dying from lung cancer.

7 is progressively stepped up to achieve symptom control and reduce the risk of exacerbations and stepped down after a per

8 aled corticosteroids (ICS) is controversial, because it can reduce the risk of future exacerbations of the disease at the

9 Sodium-glucose cotransporter 2 inhibitors reduce the risk of heart failure hospitalization and cardiova

10 midlife and highlight therapeutic windows of opportunity to reduce the risk of late-onset Alzheimer's disease.

11 rapy with aspirin and a P2Y(12) inhibitor has been shown to reduce the risk of major adverse cardiovascular events (MACE)

12 s therefore imply that suppression of de novo infection may reduce the risk of malignant transformation.

13 fectiveness (VE), we find that primary infection appears to reduce the risk of medically attended infection with that sub

14 second trimester improves maternal oral health but fails to reduce the risk of preterm birth.

15 cohort study suggest that the use of 3-piece IOL models may reduce the risk of pseudophakic VAO in children younger than

16 We examined whether FA supplementation could reduce the risk of PTD associated with maternal exposure to P

17 deling of concurrent treatment of TB and HIV to potentially reduce the risk of reactivation of TB due to HIV to inform tr

18 To reduce the risk of recurrence, patients should consume a high

19 technology used to improve the detection of tumors and can reduce the risk of recurrence.

20 Calcium alone or in combination with vitamin D may reduce the risk of SCC, but not BCC.

21 t might increase susceptibility to SARS-CoV-2 infection but reduce the risk of severe COVID-19.

22 phylaxis in elderly patients who have survived an AMI would reduce the risk of subsequent cardiovascular events during 2

23 d give recommendations for software developers and users to reduce the risk of such errors.

24 ) spike protein, used in a combined cocktail (REGN-COV2) to reduce the risk of the emergence of treatment-resistant mutan

25 minimize the necessary period of proteasome inhibition and reduce the risk of toxicity from long-term treatment.

26 cine can be applied to rapidly improve clinical outcome and reduce the risk of toxicity.

27 res to limit the dissemination at human-swine interfaces to reduce the risk of zoonotic infections and to inform pandemic

28 BCG vaccination reduced the risk of a positive baseline IGRA (relative risk [

29 Tocilizumab significantly reduced the risk of a subsequent NMOSD relapse compared with

30 twice daily plus acetylsalicylic acid (aspirin; ASA) 100 mg reduced the risk of cardiovascular events as compared with AS

31 Dapagliflozin reduced the risk of death and worsening heart failure and imp

32 Notably, a history of statin or SSRI usage reduced the risk of EAC or HGD by 49% or 61%, respectively.

33 ACNS0333 therapy significantly reduced the risk of EFS events in patients < 36 months of age

34 SVR reduced the risk of HCC.

35 % confidence interval {CI} .83-.97]; P = .01), and strongly reduced the risk of IGRA conversion (RR, 0.56 [95% CI, .40-.7

36 orrected LDL-C by 51.1 mg/dl (IQR: 33.7 to 67.2 mg/dl), and reduced the risk of MACE (hazard ratio [HR]: 0.85; 95% confid

37 on of aspirin therapy 1 to 3 months after PCI significantly reduced the risk of major bleeding by 40% compared with dual

38 LDL cholesterol lowering significantly reduced the risk of major vascular events (n=3519) in older p

39 d monoclonal antibody targeting the interleukin-6 receptor, reduced the risk of relapse in patients with neuromyelitis op

40 Adjuvant dabrafenib plus trametinib reduced the risk of relapse versus placebo in patients with r

41 high child mortality settings, seroconversion dramatically reduced the risk of severe rotavirus gastroenteritis (HR, 0.4

42 Compared to usual care, PSM significantly reduced the risk of stroke (risk ratio [RR] 0.24, 95% CI 0.08

43 IPT reduced the risk of TB by approximately 30% (aHR, 0.71 [95% C

44 he first-attempt success rate of orotracheal intubation and reduces the risk of complications when compared with direct l

45 ating HBV infection, either with IFN or NUCs, substantially reduces the risk of HCC development, even if antiviral therap

46 Our objective was to ascertain whether PCSK9 inhibition reduces the risk of PAD events or VTE after acute coronary sy

47 hey play an important role in blood pressure regulation and reducing the risk of heart failure.

48 m and they may prove beneficial in the most severe cases by reducing the risk of losing the globe altogether.

49 tive, intraoperative, and postoperative strategies aimed at reducing the risk of perioperative stroke and at improving th

50 nd ongoing research into medical therapies aimed at further reducing the risks of cardiovascular events in patients with